A patient with herpes simplex virus encephalitis is described. The 
The initial cerebrospinal fluid sample was negative for antibodies to HSV, while a second sample obtained three weeks later had a titre of 1/40. The HSV antibody titre was determined using an indirect fluorescence antibody (IFA) test according to the manufacturer's protocol (Gull laboratories Inc. Salt Lake City, Utah, USA). Briefly, slides containing reaction sites, precoated with HSV infected cells, were overlaid with 20,ul of cerebrospinal fluid and incubated at room temperature for 30 minutes. Slides were then washed with phosphate buffered saline (PBS) and the reaction sites were covered with 20 pl of fluorescein conjugated goat antihuman immunoglobulin. After 30 minutes of incubation at room temperature slides were washed with PBS and viewed under a fluorescence microscope. To determine whether HSV antibody was synthesised intrathecally, rubella antibody titre was also determined on all cerebrospinal fluid samples using the Rubascan latex agglutination test (Becton Dickinson, Cokeysville, Maryland, USA). Both cerebrospinal fluid samples from our patient contained no rubella antibodies, indicating that the HSV antibody was intrathecally synthesised and that there was no loss of blood-brain barrier.
PCR was carried out for 35 cycles with a set of primers that bracketed a 92 base pair segment unique to the HSV DNA polymerase gene (primer 1-5'-CATCACGACCCGGA-GAGGGAC-3', primer 2-5'-GGGCCAG-GCGCTTGTTGGTGTA-3', and oligonucleotide probe 5'-GTCCTCACCGCC-GAACTGAG-3').3 The primers and PCR protocol used in this report have known 
